Literature DB >> 11568456

Selenium (Se) from high-selenium broccoli is utilized differently than selenite, selenate and selenomethionine, but is more effective in inhibiting colon carcinogenesis.

J W Finley1, C D Davis.   

Abstract

The reduction in incidence of chemically-induced colon cancer by foods high in selenium (Se) was investigated in Fisher-344 rats. The foods used were high-Se broccoli (produced in a greenhouse by addition of selenate to the media surrounding the plant roots) and a processed high-Se wheat product (made by milling high-Se wheat purchased from a seleniferous area). Weanling rats were fed diets containing different amounts of Se from these foods or from selenium salts (selenite and selenate). Early in the experiment the animals were injected with a chemical carcinogen. After 11 weeks on diets animals were killed and the colons examined for preneoplastic lesions (aberrant crypts foci, ACF). ACF were significantly reduced in animals fed supra-nutritional amounts of Se from broccoli, despite the finding that Se from broccoli was poorly bioavailable. Supra-nutritional amounts of Se from high-Se processed wheat also significantly reduced aberrant crypts (AC), although pure selenomethionine, (the predominant chemical form of Se in wheat), did not significantly reduce AC. These results emphasize the need to study Se in food forms, and not extrapolate from previous studies using pure chemical forms in cancer inhibition studies. They also demonstrate that foods with high Se bioavailability are not necessarily the most efficacious for cancer incidence reduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568456     DOI: 10.1002/biof.5520140124

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  11 in total

1.  Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats.

Authors:  Ilan Aroch; Sarah Kraus; Inna Naumov; Ehud Ron; Shiran Shapira; Dina Kazanov; Nis Giladi; Alex Litvak; Shahar Lev-Ari; Aharon Hallak; Iris Dotan; Baruch Shpitz; Nadir Arber
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

2.  Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4.

Authors:  Natalie Nguyen; Arati Sharma; Nhung Nguyen; Arun K Sharma; Dhimant Desai; Sung Jin Huh; Shantu Amin; Craig Meyers; Gavin P Robertson
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-19

3.  Melanoma prevention using topical PBISe.

Authors:  Chin-Ying Chung; SubbaRao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-02

4.  Baseline selenium and prostate cancer risk: comments and open questions.

Authors:  Paul H Frankel; Robert S Parker; Fred C Madsen; Philip D Whanger
Journal:  J Natl Cancer Inst       Date:  2014-02-22       Impact factor: 13.506

5.  Molecular and biochemical characterization of the selenocysteine Se-methyltransferase gene and Se-methylselenocysteine synthesis in broccoli.

Authors:  Sangbom M Lyi; Laurence I Heller; Michael Rutzke; Ross M Welch; Leon V Kochian; Li Li
Journal:  Plant Physiol       Date:  2005-04-29       Impact factor: 8.340

6.  Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.

Authors:  Dhimant Desai; SubbaRao V Madhunapantula; Krishnegowda Gowdahalli; Arati Sharma; Raghavendragowda Chandagaludoreswamy; Karam El-Bayoumy; Gavin P Robertson; Shantu Amin
Journal:  Bioorg Med Chem Lett       Date:  2009-09-22       Impact factor: 2.823

7.  Accumulation of an organic anticancer selenium compound in a transgenic Solanaceous species shows wider applicability of the selenocysteine methyltransferase transgene from selenium hyperaccumulators.

Authors:  Marian J McKenzie; Donald A Hunter; Ranjith Pathirana; Lyn M Watson; Nigel I Joyce; Adam J Matich; Daryl D Rowan; David A Brummell
Journal:  Transgenic Res       Date:  2008-12-03       Impact factor: 2.788

8.  Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Authors:  Brian L Lindshield; Nikki A Ford; Kirstie Canene-Adams; Alan M Diamond; Matthew A Wallig; John W Erdman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

Review 9.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

10.  Effects of selenium on colon carcinogenesis induced by azoxymethane and dextran sodium sulfate in mouse model with high-iron diet.

Authors:  Jun-Hyeong Kim; Jin-Joo Hue; Bong Su Kang; Hyunji Park; Sang Yoon Nam; Young Won Yun; Jong-Soo Kim; Beom Jun Lee
Journal:  Lab Anim Res       Date:  2011-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.